Bml Capital Management, LLC Design Therapeutics, Inc. Transaction History

Bml Capital Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	SELL	$3.23 - $4.77 $1.48 Million - $2.18 Million	-457,729 Reduced 52.05%	421,749 $1.41 Billion
Q1 2024 Apr 23, 2024	SELL	$2.27 - $4.03 $340,500 - $604,500	-150,000 Reduced 14.57%	879,478 $3.54 Billion
Q4 2023 Jan 30, 2024	BUY	$1.99 - $2.76 $2.05 Million - $2.84 Million	1,029,478 New	1,029,478 $2.73 Billion

102

31M

2.3K

16.5K

Ticker DSGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,807,900
Market Cap $343M
Description
Design Therapeutics, Inc. a preclinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of genetic diseases caused by nucleotide repeat expansions. The company's portfolio of products comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ syste...

Get notified when there are updates to the investment portfolio of Bml Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bml Capital Management, LLC with notifications on news.